Richard Ian Griffiths - 25 Jun 2025 SCHEDULE 13D/A Report for Silence Therapeutics Plc Ordinary Shares, nominal value of GBP0.05 per share

Filing Manager: Richard Ian Griffiths
Reporting Manager: Richard Ian Griffiths
Security: Silence Therapeutics Plc Ordinary Shares, nominal value of GBP0.05 per share
Shares outstanding: 142M shares
Disclosed Ownership: 34.5M shares
Ownership: 24.4%
Form type: SCHEDULE 13D/A
Filing time: 25 Jun 2025, 10:24:36 UTC
Date of event: 25 Jun 2025
Previous filing: 08 May 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Richard Ian Griffiths	24.4%	34.5M	34.5M	0	/s/ Richard Ian Griffiths	Richard Ian Griffiths	0001846370
Ora Capital Limited	13.6%	19.2M	19.2M	0	/s/ Richard Ian Griffiths	Director